The NHS could save hundreds of millions of pounds every year if it used a blood flow monitor more often during surgery, the national health watchdog has said.
In its latest guidance, the National Institute for Health and Clinical Excellence (NICE) said that the CardioQ-ODM typically cuts the length of a hospital stay following high-risk surgery by two days and saves £1,000 each time it is used.
The CardioQ-ODM device monitors the amount of blood pumped by the heart with each beat, providing valuable information on a patient's fluid balance and ensuring their major organs are getting enough blood.
NICE now advises NHS hospitals to consider using the device in patients who need major or high-risk surgery, and in those who may need invasive cardiovascular monitoring.
Dr Carole Longson, director of the institute's Centre for Health Technology Evaluation, commented: 'This new device offers potential cost savings for the NHS together with improved experiences for patients.
'The Medical Technologies Committee found strong evidence for adopting CardioQ-OMD in the NHS in specific surgical settings, and we hope it will be used consistently to deliver proven clinical and cost benefits.'
Monty Mythen, clinical lead for the Department of Health's Enhanced Recovery Partnership Programme and professor of anaesthesia and critical care at University College London, said he had seen the benefits of ODM firsthand.
He explained: 'By offering a much less invasive method of fluid management during and after surgery, ODM helps patients recover more quickly. I am delighted that this guidance has highlighted the advantages of this technology, and I hope that it gives the NHS the impetus it needs to ensure better access for all.'